Angelos M. Stergiou - 12 Mar 2020 Form 4/A - Amendment Insider Report for SELLAS Life Sciences Group, Inc. (SLS)

Role
President and CEO, Director
Signature
/s/ Angelos M. Stergiou
Issuer symbol
SLS
Transactions as of
12 Mar 2020
Net transactions value
$0
Form type
4/A - Amendment
Filing time
03 Dec 2021, 16:04:08 UTC
Date Of Original Report
16 Mar 2020
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLS Common Stock 103,537 12 Mar 2020 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4/A is being filed to correct a mathematical error in Column 5 of the original Form 4 filed on March 16, 2020 regarding the amount of securities beneficially owned by the Reporting Person following the transaction. As a result of the mathematical error in Column 5 of the original Form 4 filed on March 16, 2020, Column 5 of the Form 4 filed on March 8, 2021 was incorrect and should have reflected an amount of 123,287.

Remarks:

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.